OCS
Oculis Holding Ag
NASDAQ · Pharmaceuticals
$28.48
+0.99 (+3.60%)
Open$27.61
Previous Close$27.49
Day High$28.66
Day Low$27.51
52W High$29.36
52W Low$14.00
Volume—
Avg Volume321.7K
Market Cap1.63B
P/E Ratio—
EPS$-2.17
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-4.1% upside
Current
$28.48
$28.48
Target
$27.31
$27.31
$14.95
$27.31 avg
$37.18
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 335.81M | 321.14M | 281.93M |
| Net Income | 75.81M | 72.36M | 63.56M |
| Profit Margin | 22.6% | 22.5% | 22.5% |
| EBITDA | 137.16M | 117.64M | 104.92M |
| Free Cash Flow | 80.35M | 48.21M | 59.98M |
| Rev Growth | +1.2% | -6.4% | +18.4% |
| Debt/Equity | 0.56 | 0.65 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |